Gender Differences in the Association Between the Uric Acid to High-density Lipoprotein Cholesterol Ratio and Diabetes Risk: a Mediation Analysis of C-reactive Protein, Triglycerides, and Insulin Resistance

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2024 Dec 19

PMID 39696515

Authors

Jianming Yin

Chuanjie Zheng

Zhan Li

Ying Chang

Lingyong Cao

Yiqian Qu

Affiliations

Soon will be listed here.

Abstract

Background: The uric acid to high-density lipoprotein cholesterol ratio (UHR) has emerged as a novel metabolic marker and is proven to be associated with diabetes risk. However, there is still a lack of systematic research regarding its role in gender differences and underlying mechanisms. This study aims to assess the association of UHR with diabetes risk in the context of gender differences and to investigate its mediation effects through metabolic and inflammatory pathways.

Methods: This study utilized data from NHANES 2005-2010 and included 6,843 adult participants. Multivariate logistic regression was employed to assess the association between UHR and diabetes risk, and restricted cubic spline (RCS) along with correlation analysis was applied to explore its relationship with metabolic risk factors. Multiple mediation analysis was conducted to evaluate the mediating effects of homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides (TG), and C-reactive protein (CRP) on the association between UHR and diabetes risk.

Results: In the overall population, UHR was significantly positively associated with diabetes risk, but gender-stratified analysis revealed a stronger predictive effect in women. In the unadjusted model, every unit increase in UHR was linked to an 18.6% increase in diabetes risk in women (p < 0.001). In the quartile analysis, women in the highest quartile showed an 8.49-fold increased risk of diabetes (OR = 8.494, 95% CI: 5.542-13.019, p < 0.001), whereas no significant association was observed in men (p > 0.05). Mediation analysis revealed that HOMA-IR was the main mediator of the relationship between UHR and diabetes risk, with mediation effects of 64.55%, 118.38%, and 39.09% in the overall population, men, and women, respectively. Additionally, the mediation effect of TG was stronger in men (36.78%) and weaker in women (17.31%). The mediation effect of CRP was relatively minimal across all groups, accounting for 7.62% in men and 2.67% in women.

Conclusion: This study demonstrates that the association between UHR and diabetes risk exhibits gender differences, with higher diabetes risk observed in women, while men show stronger mediation effects in insulin resistance, lipid metabolism, and inflammatory response.

References

Bonora E, Targher G, Alberiche M, Bonadonna R, Saggiani F, Zenere M . Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000; 23(1):57-63. DOI: 10.2337/diacare.23.1.57. View

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

Kocak M, Aktas G, Erkus E, Sincer I, Atak B, Duman T . Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019; 65(1):9-15. DOI: 10.1590/1806-9282.65.1.9. View

Bazmandegan G, Dehghani M, Karimifard M, Kahnooji M, Balaee P, Zakeri M . Uric acid to HDL ratio: A marker for predicting incidence of metabolic syndrome in patients with type II diabetes. Nutr Metab Cardiovasc Dis. 2024; 34(4):1014-1020. DOI: 10.1016/j.numecd.2023.12.022. View

Khera A, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke M, Jafri K . Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011; 364(2):127-35. PMC: 3030449. DOI: 10.1056/NEJMoa1001689. View

Zhou X, Xu J . Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus. J Diabetes Investig. 2023; 15(1):113-120. PMC: 10759725. DOI: 10.1111/jdi.14086. View

Balci S, Atak B, Duman T, Ozkul F, Aktas G . A novel marker for prediabetic conditions: Uric acid-to-HDL cholesterol ratio. Bratisl Lek Listy. 2024; 125(3):145-148. DOI: 10.4149/BLL_2023_130. View

MacDonald I . A review of recent evidence relating to sugars, insulin resistance and diabetes. Eur J Nutr. 2016; 55(Suppl 2):17-23. PMC: 5174139. DOI: 10.1007/s00394-016-1340-8. View

Ye X, Kong W, Zafar M, Chen L . Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019; 18(1):48. PMC: 6466658. DOI: 10.1186/s12933-019-0851-z. View

10.

Grundy S . Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999; 83(9B):25F-29F. DOI: 10.1016/s0002-9149(99)00211-8. View

11.

Beshara A, Cohen E, Goldberg E, Lilos P, Garty M, Krause I . Triglyceride levels and risk of type 2 diabetes mellitus: a longitudinal large study. J Investig Med. 2016; 64(2):383-7. DOI: 10.1136/jim-2015-000025. View

12.

Wei X, Zhang M, Huang S, Lan X, Zheng J, Luo H . Hyperuricemia: A key contributor to endothelial dysfunction in cardiovascular diseases. FASEB J. 2023; 37(7):e23012. DOI: 10.1096/fj.202300393R. View

13.

Lu W, Xu Y, Shao X, Gao F, Li Y, Hu J . Uric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders. Sci Rep. 2015; 5:12144. PMC: 4503982. DOI: 10.1038/srep12144. View

14.

Muniyappa R, Lee S, Chen H, Quon M . Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2007; 294(1):E15-26. DOI: 10.1152/ajpendo.00645.2007. View

15.

Wallace T, Levy J, Matthews D . Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6):1487-95. DOI: 10.2337/diacare.27.6.1487. View

16.

Yu W, Cheng J . Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective. Front Pharmacol. 2020; 11:582680. PMC: 7701250. DOI: 10.3389/fphar.2020.582680. View

17.

Naqvi S, Naveed S, Ali Z, Ahmad S, Asadullah Khan R, Raj H . Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus. Cureus. 2017; 9(6):e1347. PMC: 5509244. DOI: 10.7759/cureus.1347. View

18.

Mugabo Y, Li L, Renier G . The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Curr Diabetes Rev. 2009; 6(1):27-34. DOI: 10.2174/157339910790442628. View

19.

Shi L, Tan G, Zhang K . Relationship of the Serum CRP Level With the Efficacy of Metformin in the Treatment of Type 2 Diabetes Mellitus: A Meta-Analysis. J Clin Lab Anal. 2014; 30(1):13-22. PMC: 6807049. DOI: 10.1002/jcla.21803. View

20.

Oliveri A, Rebernick R, Kuppa A, Pant A, Chen Y, Du X . Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank. Nat Genet. 2024; 56(2):212-221. PMC: 10923176. DOI: 10.1038/s41588-023-01625-2. View